Saturday - July 12, 2025
FTC Issues Warning Letter to Teva Branded Pharmaceutical Products R&D
May 22, 2025
WASHINGTON, May 22 -- The Federal Trade Commission Bureau of Competition issued the following warning letter on May 21, 2025:

* * *

Teva Branded Pharmaceutical

Products R&D, Inc.

Attn: Legal Counsel

c/o Corporate Creations Network Inc.

3411 Silverside Road

Tatnall Building, Ste. 104 Wilmington, New Castle, DE 19810

*

Brian Savage, SVP and General Counsel

Global Li . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products